Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardio-Neuromodulation in Humans, 3th Study

NCT04755101 is registered in ClinicalTrials.gov with Imelda Hospital, Bonheiden as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04755101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardio-Neuromodulation in Humans, 3th Study
Lead sponsor
Imelda Hospital, Bonheiden
Phase
Not applicable
Overall status
Recruiting
Start date
March 24, 2021
Completion date
December 31, 2026
Enrollment
110 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

syncope, syncope, neurogenic